January 19 AU governement allocated an additional $36.8 million for Parkinson's research.
The Hon. Greg Hunt MP Minister for Health MEDIA RELEASE 30 January 2019 $36.8 million for Parkinson’s disease The Liberal National Government is making a significant investment of $36.8 million for Parkinson’s medical research through the Garvin’s Institute’s Australian Parkinson Mission and in Parkinson’s nurses to improve the life of people living the disease and ultimately to find a cure for this devastating condition. Parkinson’s disease is recognised as the second most common neurodegenerative disorder in Australia. More than 100,000 Australians endure its progressive and debilitating symptoms – and without a medical breakthrough, this number is expected to double in 15 years. Our Government is providing $30 million over five years to the Garvan Institute of Medical Research to trial promising drugs to reduce the progression of the disease and allow people to live in their homes longer. Up to 1,000 Australians from Victoria, NSW and Queensland living with Parkinson’s will test the effectiveness of four repurposed drugs, revolutionising our understanding of Parkinson’s, identifying new treatment targets and discovering new drugs. The $30 million funding comes from our landmark Medical Research Future Fund, which is giving unprecedented support to the best and brightest minds from our research community. The MRFF is an endowment fund, which will mature at $20 billion, providing a sustainable source of funding for vital medical research. It is the single largest boost in health and medical research funding in Australia’s history. The fund will double Australia’s investment in health and medical research and further enhance our global reputation for research excellence. A further $6.8 million over four years will be provided to Primary Health Networks to improve access to specialised nursing care in the community for people living with movement disorders, including Parkinson’s disease. Nurses play a critical role in preventing and managing chronic disease and in improving timely access to health care for Australian communities. $36.8 million for Parkinson’s disease
Market Data 
Markets 
